1 From the Medical Service, Veterans Administration Hospital, and the Department of Medicine, Medical College of Virginia, Richmond, Va.
Guanethidine, a new synthetic hypotensive drug that probably interferes with release of norepinephrine from sympathetic nerve endings and that does not inhibit parasympathetic activity, has proved an effective agent in reducing blood pressure in 25 hypertensive patients studied for periods up to 6 months. Untoward effects have been limited to orthostatic hypotension and mild diarrhea. The drug apparently lowers blood pressure by reduction in cardiac output rather than by relaxation of the arterioles. Reduction in renal blood flow and glomerular filtration rate accompanied administration of the drug, but in no case did progressive azotemia or oliguria occur. This agent is an extremely potent hypotensive drug with a remarkably prolonged duration of action and with none of the parasympatholytic side effects produced by ganglionic-blocking agents.
© 1960 American Heart Association, Inc.
Circulatory Effects of Guanethidine
Clinical, Renal, and Cardiac Responses to Treatment with a Novel Antihypertensive Drug
This article has been cited by other articles:
![]() |
A. D. Bender The Hemodynamics of Hypertension and Anti Hypertensive Therapy Angiology, September 1, 1966; 17(9): 627 - 639. [PDF] |
||||
![]() |
A. A. Rubin Hemodynamic Aspects of Certain Antihypertensive Agents Angiology, February 1, 1963; 14(2): 74 - 78. [PDF] |
||||
![]() |
M. J. Kert, A. M. Dashe, R. H. Mailman, S. I. Roth, and A. Zager A Long-Term Study of Combined Guanethidine and Hydrochlorothiazide Therapy in the Management of Hypertension Angiology, November 1, 1962; 13(11): 511 - 519. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1960 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |